Henry Schein Stock
Henry Schein, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Country
- United States
- CEO
- Frederick Lowery
- Employees
- 25,000
- Market cap
- $9.6 B
- IPO
- 03/11/1995
Henry Schein, Inc. is a global leader in the Healthcare sector, specializing in Medical - Distribution. Headquartered in Melville, USA, the company was established in 1932. The business operations are organized into two principal segments, which are Health Care Distribution and Technology and Value-Added Services.…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Henry Schein stock: price history
1D
-0.7%
1W
+2.8%
1M
-0.4%
6M
+9.6%
YTD
+14.3%
1Y
+39.3%
2Y
+20.4%
5Y
+11.5%
10Y
+43.6%
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~67% stronger price swings than usual
Henry Schein stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
2 more assignments (Enabler/Second row) Pro-only.
Henry Schein, Inc. operates as a global healthcare provider with two primary business segments. The Healthcare Distribution segment represents the core business and encompasses the distribution of dental supplies including consumables, specialized equipment, as well as medical products including pharmaceuticals and surgical instruments. Additionally, repair services for technical equipment are offered. The Technology and Value-Added Services segment focuses on software solutions for practice management as well as complementary services such as IT infrastructure, professional continuing education offerings, and financial assistance to support practitioners in physician offices and laboratories.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Narrow
- Moat type
- Switching costs
- Capital intensity
- Medium
- Customer concentration
- Low
Ask the agents about Henry Schein
Analyst assessment of Henry Schein
PRICE TARGET LOW
US$64.00
CONSENSUS
US$92.30
MEDIAN
US$94.50
PRICE TARGET HIGH
US$110.00
0
STRONG BUY
17
BUY
14
HOLD
3
SELL
0
STRONG SELL
34
TOTAL · Buy
As of: 14/10/2026
Henry Schein stock metrics
P/E
24.97
P/B
3.1
EV/EBITDA
12.71
RETURN ON EQUITY
3.0%
NET MARGIN
2.7%
DEBT/EQUITY
1.21
DIVIDEND YIELD
0.0%
AS OF
27/06/2026
Free float & liquidity
FREE FLOAT
82.3%
FLOAT SHARES
91,710,474
AVG. DAILY VOLUME (30D)
1,216,175
Insider transactions (SEC)
Albertini Andrea
Albertini Andrea
DANIEL WILLIAM K
BERGMAN STANLEY M
BERGMAN STANLEY M
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Henry Schein stock
What does Henry Schein do?
Henry Schein, Inc. is a company in the Healthcare sector, Medical - Distribution industry, headquartered in United States.
The CEO is Frederick Lowery, the company employs around 25,000 people.
The IPO was on 03/11/1995; the stock trades on NASDAQ under the ticker HSIC.
What do analysts say about Henry Schein stock?
34 analysts rate the stock, the consensus is Buy (as of 14/10/2026).
The average price target is US$92.30, ranging from US$64.00 to US$110.00, with a median of US$94.50.
This is an external assessment, not a statement by Market Jury.
When does Henry Schein report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 67% stronger than usual.
Does Henry Schein pay a dividend?
No, Henry Schein currently does not pay a dividend.
Which stocks are comparable to Henry Schein?
Comparable stocks include McKesson, Cencora, Cardinal Health, DocMorris, Eli Lilly and Company, Johnson & Johnson, AbbVie and Merck &.
How can I get Henry Schein stock analyzed?
Clicking "Analyze stock" lets five strategies assess Henry Schein against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.